Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study

Objectives: Vancomycin is the treatment of choice for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia; however, its use has been subject to scrutiny due to failure in severe infections. Ceftaroline fosamil (CPT-F) is approved for MRSA acute bacterial skin and skin structure infections,...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Samia Arshad, Vanthida Huang, Pamela Hartman, Mary B. Perri, Daniela Moreno, Marcus J. Zervos
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2017-04-01
Saila:	International Journal of Infectious Diseases
Gaiak:	Methicillin-resistant Staphylococcus aureus Bacteremia Bloodstream infection Ceftaroline fosamil
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S120197121730022X
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!